PharmaShots | Incisive News in 3 Shots

Subscribe Now

small cell lung cancer

Disease of the Month – Small Cell Lung Cancer

Disease of the Month – Small Cell Lung Cancer

July 18, 2024

Takeda Entered into an Exclusive License Agreement with Puma Biotechnology for the Development and Commercialization of Alisertib

Takeda Entered into an Exclusive License Agreement with Puma Biotechnology for the Development and Commercialization of Alisertib

September 21, 2022

AstraZeneca Presents the Updated Results of Imfinzi (durvalumab) in P-III CASPIAN Trial for the Treatment of Extensive-Stage Small Cell Lung Cancer at ESMO 2021

AstraZeneca Presents the Updated Results of Imfinzi (durvalumab) in P-III CASPIAN Trial for the Treatment of Extensive-Stage Small...

September 20, 2021

AstraZeneca's Imfinzi (durvalumab) Receives NMPA's Approval as a 1L Treatment of Extensive-Stage Small Cell Lung Cancer

AstraZeneca's Imfinzi (durvalumab) Receives NMPA's Approval as a 1L Treatment of Extensive-Stage Small Cell Lung Cancer

July 19, 2021

G1 Therapeutics and Boehringer Ingelheim Launch Cosela (trilaciclib) in the US

G1 Therapeutics and Boehringer Ingelheim Launch Cosela (trilaciclib) in the US

March 3, 2021

Jazz Pharma and PharmaMar's Zepzelca Fail to Meet its Primary Endpoint in P-III ATLANTIS Study for SCLC

Jazz Pharma and PharmaMar's Zepzelca Fail to Meet its Primary Endpoint in P-III ATLANTIS Study for SCLC

December 4, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us